LV10200B - Therapeutic agent - Google Patents

Therapeutic agent

Info

Publication number
LV10200B
LV10200B LVP-93-624A LV930624A LV10200B LV 10200 B LV10200 B LV 10200B LV 930624 A LV930624 A LV 930624A LV 10200 B LV10200 B LV 10200B
Authority
LV
Latvia
Prior art keywords
therapeutic agent
purified chymopapain
papaya proteinase
composition
ppiii
Prior art date
Application number
LVP-93-624A
Other languages
English (en)
Other versions
LV10200A (lv
Inventor
Alan John Barret
David John Buttle
Daniel Hulbert Rich
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of LV10200A publication Critical patent/LV10200A/xx
Publication of LV10200B publication Critical patent/LV10200B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
LVP-93-624A 1989-04-28 1993-06-19 Therapeutic agent LV10200B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898909836A GB8909836D0 (en) 1989-04-28 1989-04-28 Therapeutic agent
PCT/EP1990/000647 WO1990013561A1 (fr) 1989-04-28 1990-04-27 Agent therapeutique

Publications (2)

Publication Number Publication Date
LV10200A LV10200A (lv) 1994-10-20
LV10200B true LV10200B (en) 1995-04-20

Family

ID=10655944

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-624A LV10200B (en) 1989-04-28 1993-06-19 Therapeutic agent

Country Status (34)

Country Link
US (2) US5380656A (fr)
EP (1) EP0470136B1 (fr)
JP (1) JPH04506003A (fr)
KR (1) KR920701241A (fr)
CN (1) CN1047340A (fr)
AT (1) ATE107660T1 (fr)
AU (1) AU631641B2 (fr)
BG (1) BG60916B1 (fr)
CA (1) CA2056402C (fr)
DD (1) DD296960A5 (fr)
DE (1) DE69010199T2 (fr)
DK (1) DK0470136T3 (fr)
EG (1) EG19583A (fr)
ES (1) ES2055427T3 (fr)
FI (1) FI914995A0 (fr)
GB (1) GB8909836D0 (fr)
GR (1) GR1001011B (fr)
HR (1) HRP930700A2 (fr)
HU (2) HUT58345A (fr)
IE (1) IE64351B1 (fr)
IL (1) IL94227A (fr)
IN (2) IN170683B (fr)
LT (1) LT3827B (fr)
LV (1) LV10200B (fr)
MX (1) MX20503A (fr)
NO (1) NO914206L (fr)
NZ (1) NZ233475A (fr)
PL (1) PL166810B1 (fr)
PT (1) PT93921B (fr)
RO (1) RO112032B1 (fr)
RU (1) RU2074891C1 (fr)
WO (1) WO1990013561A1 (fr)
YU (1) YU87090A (fr)
ZA (1) ZA903228B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909836D0 (en) * 1989-04-28 1989-06-14 Boots Co Plc Therapeutic agent
WO1992014696A2 (fr) * 1991-02-22 1992-09-03 The Du Pont Merck Pharmaceutical Company α-AMINOALDEHYDES SUBSTITUES ET LEURS DERIVES
CA2061861A1 (fr) * 1991-03-04 1992-09-05 Jonathan Duvick Polypeptides vegetaux ayant une activite inhibitrice vis-a-vis des microorganismes pathogenes
CN1060519C (zh) * 1991-05-09 2001-01-10 广西亚热带作物研究所 桄榔植物蛋白酶的提取方法
AU668110B2 (en) * 1991-10-14 1996-04-26 Cash Engineering Research Pty Ltd Inlet control combination for a compressor system
US6753006B1 (en) 1993-02-22 2004-06-22 American Bioscience, Inc. Paclitaxel-containing formulations
WO1994028012A1 (fr) * 1993-05-28 1994-12-08 Warner-Lambert Company Hydroxamates inhibiteurs de l'enzyme de conversion de l'endotheline
US6395897B1 (en) 1999-03-02 2002-05-28 Boehringer Ingelheim Pharmaceuticals, Inc. Nitrile compounds useful as reversible inhibitors of #9 cathepsin 5
JP2002539192A (ja) * 1999-03-15 2002-11-19 アクシス・ファーマシューティカルズ・インコーポレイテッド プロテアーゼ阻害剤としての新規な化合物及び組成物
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
US6703040B2 (en) 2000-01-11 2004-03-09 Intralytix, Inc. Polymer blends as biodegradable matrices for preparing biocomposites
US7935337B2 (en) 2002-12-25 2011-05-03 Hiromichi Komori Method of therapy for degenerative intervertebral discs
US7169405B2 (en) * 2003-08-06 2007-01-30 Warsaw Orthopedic, Inc. Methods and devices for the treatment of intervertebral discs
US20080069907A1 (en) * 2004-07-06 2008-03-20 Chikao Morimoto Compositions for Cancer Prevention, Treatment, or Amelioration Comprising Papaya Extract
CN1320111C (zh) * 2004-08-09 2007-06-06 王美岭 一种制备木瓜凝乳酶的方法
US20060241566A1 (en) * 2005-04-11 2006-10-26 Orthox, Llc Nucleus Extraction from Spine Intervertebral Disc
US8642059B2 (en) 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for intervertebral discs
US8642060B2 (en) * 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for osteal growth
US7879027B2 (en) * 2006-04-24 2011-02-01 Warsaw Orthopedic, Inc. Controlled release devices for fusion of osteal structures
US7771414B2 (en) * 2006-04-24 2010-08-10 Warsaw Orthopedic, Inc. Controlled release devices for therapeutic treatments of spinal discs
US20070265633A1 (en) * 2006-05-11 2007-11-15 Moon Jon K Implement and method to extract nucleus from spine intervertebral disc
US8257938B2 (en) * 2009-02-27 2012-09-04 Medical Diagnostic Laboratories, Llc Hemolysin and its protein fragments in sero-detection of Anaplasma phagocytophilum
JPWO2013038936A1 (ja) * 2011-09-13 2015-03-26 タカラバイオ株式会社 ペルオキシダーゼ反応の停止方法及び反応停止剤
WO2014004512A1 (fr) 2012-06-25 2014-01-03 Surmodics, Inc. Poly(étherestéramides) biodégradables et utilisations dans des articles médicaux

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE270723C (fr) *
US2313875A (en) * 1940-12-17 1943-03-16 Eugene F Jansen Proteolytic enzyme process
US3320131A (en) * 1964-10-23 1967-05-16 Baxter Laboratories Inc Method for the treatment of herniation of intervertebral discs
US3558433A (en) * 1967-11-07 1971-01-26 Baxter Laboratories Inc Process for purification of chymopapain
YU40433B (en) * 1975-02-20 1986-02-28 Lek Tovarna Farmacevtskih Process for obtaining pure, proteolytically active anzymes
DE3212846A1 (de) 1981-04-13 1982-11-04 Sintokogio, Ltd., Nagoya, Aichi Apparat und verfahren zum herstellen eines kerns
US4719108A (en) * 1981-05-13 1988-01-12 Smith Laboratories, Inc. Chymopapain composition and method for its use
DE3278934D1 (en) * 1981-05-13 1988-09-29 Flint Lab Inc Improved chymopapain and method for its production and use
US4439423A (en) * 1981-05-13 1984-03-27 Smith Laboratories, Inc. Chymopapain and method for its use
US4374926A (en) * 1981-05-13 1983-02-22 Smith Laboratories, Inc. Method for the production of improved chymopapain
GB2124233B (en) * 1982-07-19 1985-09-18 Nat Res Dev Synthetic peptides and their preparation
GB2156821A (en) * 1984-04-03 1985-10-16 Simmons James W Process for purifying chymopapain
HU196624B (en) * 1986-12-08 1988-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing chymopapain with high specific activity
GB8909836D0 (en) * 1989-04-28 1989-06-14 Boots Co Plc Therapeutic agent

Also Published As

Publication number Publication date
AU5547290A (en) 1990-11-29
BG60916B1 (bg) 1996-06-28
AU631641B2 (en) 1992-12-03
GR1001011B (el) 1993-03-31
ATE107660T1 (de) 1994-07-15
FI914995A0 (fi) 1991-10-23
HRP930700A2 (en) 1995-06-30
IL94227A0 (en) 1991-01-31
LT3827B (en) 1996-03-25
KR920701241A (ko) 1992-08-11
BG95362A (bg) 1993-12-24
DE69010199T2 (de) 1994-10-13
CA2056402A1 (fr) 1990-10-29
PT93921B (pt) 1996-10-31
IE64351B1 (en) 1995-07-26
EP0470136A1 (fr) 1992-02-12
RO112032B1 (ro) 1997-04-30
NO914206D0 (no) 1991-10-25
PL166810B1 (pl) 1995-06-30
NO914206L (no) 1991-12-17
EG19583A (en) 1995-09-30
JPH04506003A (ja) 1992-10-22
WO1990013561A1 (fr) 1990-11-15
LV10200A (lv) 1994-10-20
ZA903228B (en) 1990-12-28
US5468480A (en) 1995-11-21
CA2056402C (fr) 1999-11-16
ES2055427T3 (es) 1994-08-16
IL94227A (en) 1994-12-29
IE901538L (en) 1990-10-28
MX20503A (es) 1993-12-01
IN173230B (fr) 1994-03-12
YU87090A (sh) 1992-09-07
HU211746A9 (en) 1995-12-28
DE69010199D1 (de) 1994-07-28
PT93921A (pt) 1990-11-20
DK0470136T3 (da) 1994-08-01
HU903342D0 (en) 1992-01-28
GB8909836D0 (en) 1989-06-14
EP0470136B1 (fr) 1994-06-22
RU2074891C1 (ru) 1997-03-10
LTIP1645A (en) 1995-07-25
US5380656A (en) 1995-01-10
GR900100315A (en) 1991-09-27
DD296960A5 (de) 1991-12-19
HUT58345A (en) 1992-02-28
NZ233475A (en) 1991-10-25
CN1047340A (zh) 1990-11-28
IN170683B (fr) 1992-05-02

Similar Documents

Publication Publication Date Title
IL94227A0 (en) Therapeutic agent
MY129998A (en) Saccharin derivative proteolytic enzyme inhibitors
MY120235A (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives
MY110104A (en) Saccharin derivative proteolytic enzyme inhibitors
CA2290520A1 (fr) Inhibition de l'activite de la p38 kinase par des aryl-urees
EP0423214A4 (en) Purification and administration of dna repair enzymes
GEP20012448B (en) Tissue Plasminogen Activators (Improved Variants)
ES2000743A6 (es) Estuche y procedimiento para preparar una unidad de dosificacion de activador de plasminogeno de tejidos humanos.
GR871488B (en) New antibiotics
DE69333639D1 (en) Trypsininhibitoren
ES2002053A6 (es) Procedimiento para la obtencion de peptidos inihiobidores de renina que contienen grupos hidroxi.
GEP20022672B (en) Pharmaceutical Composition
HU9200438D0 (en) Process for the production of novel cumarin derivatives and their analogues preventing tumor-growth and cell-proliferation in mammals, and of medical preparations containing them
AU7037591A (en) Stabilization of t-pa pro
CA2262582A1 (fr) Hcg et ses derives comme inhibiteurs de metalloproteases de matrice
ZA902436B (en) Purification of c.pseudotuberculosis toxin,and cloning and expression of toxin gene
UA10676A (uk) Штаммбактерій васіllus сіrсulаns бт вкпм в-5622продуцеhт комплексу пектолітичhих фермеhтів і ксілаhази
MX9800891A (es) Mocarhagina, una proteasa del veneno de cobra y usso terapeuticos de la misma.